Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 4/2015

01-12-2015 | Original Article

The effect of Glutathione-S-transferases in the susceptibility to bladder cancer

Authors: G. G. Ceylan, C. Ceylan, S. Taşdemir, A. Gözalan

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2015

Login to get access

Abstract

Background

Urinary bladder cancer is a quite common cancer type in men and women all over the world. Genetic polymorphisms of xenobiotic-metabolizing enzymes could increase individual susceptibility to various cancer types.

Aims

The aim of our study is to evaluate the rate of these polymorphisms in a group of patients from Central Anatolia.

Methods

Our study subjects consist of 65 men with histopathologically confirmed bladder TCC and 70 cancer-free control subjects. Restriction fragment length polymorphism (RFLP) method was used for the detection of polymorphisms of GSTT1 and GSTM1.

Results

There was no association between bladder cancer and GSTM1 polymorphism (ORs = 0.64, 95 % CI = 0.32–1.29), but the probability of bladder cancer in patients with GSTT1 null genotype (67.9 %), was significantly higher from the probability of bladder cancer with GSTT1 normal genotype (43.0 %) statistically (ORs = 2.8, 95 % CI = 1.16–6.75).

Conclusion

Polymorphisms of these genes have been assessed to evaluate the relative risk of various cancers. Our intention is to continue this study with larger series of bladder cancer patients in a group of Turkish population from Central Anatolia.
Literature
1.
go back to reference Ferlay J, Bray F, Pisani P, Parkin DM, GLOBOCAN (2002) Cancer incidence, mortality and prevalence worldwide. IARC cancer base no. 5, version 1.0. International agency for research on cancer Ferlay J, Bray F, Pisani P, Parkin DM, GLOBOCAN (2002) Cancer incidence, mortality and prevalence worldwide. IARC cancer base no. 5, version 1.0. International agency for research on cancer
2.
go back to reference Konety BR, Williams RD (2004) Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladder. BJU Int 94:18–21CrossRefPubMed Konety BR, Williams RD (2004) Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladder. BJU Int 94:18–21CrossRefPubMed
3.
4.
go back to reference Heney NM (1992) Natural history of superficial bladder cancer. Prognostic features and long-term disease course. Urol Clin NorthAm 19:429–433 Heney NM (1992) Natural history of superficial bladder cancer. Prognostic features and long-term disease course. Urol Clin NorthAm 19:429–433
5.
go back to reference Cohen SM, Shirai T, Steineck G (2000) Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol (Suppl) 205:105–115CrossRef Cohen SM, Shirai T, Steineck G (2000) Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol (Suppl) 205:105–115CrossRef
6.
go back to reference Stern MC, Johnson LR, Bell DA, Taylor JA (2000) XPD Codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11:1004–1011 Stern MC, Johnson LR, Bell DA, Taylor JA (2000) XPD Codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11:1004–1011
7.
go back to reference Sanyal S, Festa F, Sakano S et al (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25:729–734CrossRefPubMed Sanyal S, Festa F, Sakano S et al (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25:729–734CrossRefPubMed
8.
go back to reference Safarinejad MR, Shafiei N, Safarinejad S (2010) The association of glutathione-S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) with idiopathic male infertility. J Hum Genet 55:565–570CrossRefPubMed Safarinejad MR, Shafiei N, Safarinejad S (2010) The association of glutathione-S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) with idiopathic male infertility. J Hum Genet 55:565–570CrossRefPubMed
9.
go back to reference Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kelsey KT (2005) Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett 219:63–69CrossRefPubMed Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kelsey KT (2005) Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett 219:63–69CrossRefPubMed
10.
go back to reference Srivastava DS, Kumar A, Mittal B, Mittal RD (2004) Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India. Arch Toxicol 78:430–434CrossRefPubMed Srivastava DS, Kumar A, Mittal B, Mittal RD (2004) Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India. Arch Toxicol 78:430–434CrossRefPubMed
11.
go back to reference Shao J, Gu M, Zhang Z, Xu Z, Hu Q, Qian L (2008) Genetic variants of the cytochrome P450 and glutathione S-transferase associated with risk of bladder cancer in a south-eastern Chinese population. Int J Urol 15:216–221CrossRefPubMed Shao J, Gu M, Zhang Z, Xu Z, Hu Q, Qian L (2008) Genetic variants of the cytochrome P450 and glutathione S-transferase associated with risk of bladder cancer in a south-eastern Chinese population. Int J Urol 15:216–221CrossRefPubMed
12.
go back to reference Sobti RC, Al-Badran AI, Sharma S, Sharma SK, Krishan A, Mohan H (2005) Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet Cytogenet 156:68–73CrossRefPubMed Sobti RC, Al-Badran AI, Sharma S, Sharma SK, Krishan A, Mohan H (2005) Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet Cytogenet 156:68–73CrossRefPubMed
13.
14.
go back to reference Salagovic J, Kalina I, Stubna J, Habalová V, Hrivnák M, Valanský L, Kohút A, Biros E (1998) Genetic polymorphism of glutathione S-transferase M1 and T1 and risk factor in lung and bladder cancer. Neoplasma 45:312–317PubMed Salagovic J, Kalina I, Stubna J, Habalová V, Hrivnák M, Valanský L, Kohút A, Biros E (1998) Genetic polymorphism of glutathione S-transferase M1 and T1 and risk factor in lung and bladder cancer. Neoplasma 45:312–317PubMed
15.
go back to reference Singh M, Shah PP, Singh AP, Ruwali M, Mathur N, Pant MC, Parmar D (2008) Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Mutat Res 638:184–194CrossRefPubMed Singh M, Shah PP, Singh AP, Ruwali M, Mathur N, Pant MC, Parmar D (2008) Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Mutat Res 638:184–194CrossRefPubMed
16.
go back to reference Smits KM, Gaspari L, Weijenberg MP et al (2003) Interaction between smoking, GSTM1 deletion, and colorectal cancer: results from the GSEC study. Biomarkers 8:299–310CrossRefPubMed Smits KM, Gaspari L, Weijenberg MP et al (2003) Interaction between smoking, GSTM1 deletion, and colorectal cancer: results from the GSEC study. Biomarkers 8:299–310CrossRefPubMed
17.
go back to reference Lee SJ, Cho SH, Park SK et al (2002) Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk. Cancer Lett 28(177):173–179CrossRef Lee SJ, Cho SH, Park SK et al (2002) Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk. Cancer Lett 28(177):173–179CrossRef
18.
go back to reference Steinhoff C, Franke KH, Golka K, Thier R, Römer HC, Rötzel C, Ackermann R, Schulz WA (2000) Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 74:521–526CrossRefPubMed Steinhoff C, Franke KH, Golka K, Thier R, Römer HC, Rötzel C, Ackermann R, Schulz WA (2000) Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 74:521–526CrossRefPubMed
19.
go back to reference Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW (1998) GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 22:129–138CrossRefPubMed Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW (1998) GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 22:129–138CrossRefPubMed
20.
go back to reference Zeng FF, Liu SY, Wei W et al (2010) Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: a meta-analysis. Clin Exp Med. 10:59–68CrossRefPubMed Zeng FF, Liu SY, Wei W et al (2010) Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: a meta-analysis. Clin Exp Med. 10:59–68CrossRefPubMed
21.
go back to reference Franekova M, Halasova E, Bukovska E, Luptak J, Dobrota D (2008) Gene polymorphisms in bladder cancer. Urol Oncol 26(1):1–8CrossRefPubMed Franekova M, Halasova E, Bukovska E, Luptak J, Dobrota D (2008) Gene polymorphisms in bladder cancer. Urol Oncol 26(1):1–8CrossRefPubMed
22.
go back to reference Katoh T, Inatomi H, Kim H, Yang M, Matsumoto T, Kawamoto T (1998) Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk. Cancer Lett 132:147–152CrossRefPubMed Katoh T, Inatomi H, Kim H, Yang M, Matsumoto T, Kawamoto T (1998) Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk. Cancer Lett 132:147–152CrossRefPubMed
Metadata
Title
The effect of Glutathione-S-transferases in the susceptibility to bladder cancer
Authors
G. G. Ceylan
C. Ceylan
S. Taşdemir
A. Gözalan
Publication date
01-12-2015
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 4/2015
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-014-1200-6

Other articles of this Issue 4/2015

Irish Journal of Medical Science (1971 -) 4/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.